Hemodialysis & Peritoneal Dialysis Market to Reach $141.5 Billion by 2031, Driven by Rising ESRD Burden and Expansion of Home-Based Therapies

Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031
According to MarketsandMarkets Trademark , The global Hemodialysis and peritoneal dialysis market [https://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 102.7 billion in 2026 to USD 141.5 billion by 2031, at a CAGR of 6.6% during the forecast period. Market growth is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), fueled by rising rates of type 2 diabetes, hypertension, and aging populations worldwide.

Browse 480 market data Tables and 78 Figures spread through 500 Pages and in-depth TOC on "Hemodialysis & Peritoneal Dialysis Market ".

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

The growing adoption of home-based dialysis therapies, supported by favorable reimbursement policies such as the CMS ESRD Prospective Payment System in the US and government-backed access programs in emerging markets, is significantly expanding the global patient base. In addition, advancements in dialysis technologies, including high-volume hemodiafiltration systems and AI-assisted therapy management platforms, are improving treatment outcomes and accelerating clinical adoption.

In-Center Hemodialysis Services Segment Leads Market

The in-center hemodialysis services segment is expected to account for the largest share of the market during the forecast period. The majority of ESRD patients continue to receive treatment at licensed dialysis centers due to access to trained clinical staff, advanced equipment, and emergency care support.

Expansion of dialysis center networks across North America, Europe, and Asia Pacific, along with stable reimbursement frameworks, continues to reinforce the dominance of this segment. In-center hemodialysis remains the standard of care, particularly for patients with complex comorbidities and those requiring acute renal support.

ESRD Segment Drives Long-Term Demand

By disease indication, the end-stage renal disease (ESRD) segment is projected to register the highest CAGR through 2031. ESRD requires lifelong renal replacement therapy in the absence of transplantation, creating a recurring and expanding demand base for dialysis products and services.

The increasing global burden of diabetes and hypertension, combined with aging demographics, is contributing to a steady rise in ESRD cases. Additionally, improved early detection and screening programs are enrolling more patients into treatment pathways, further strengthening market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Asia Pacific Emerges as Fastest-Growing Region

Asia Pacific is expected to register the highest growth rate during the forecast period, driven by expanding healthcare infrastructure, rising healthcare expenditures, and increasing access to dialysis services.

Countries such as China and India are leading growth, supported by government initiatives to improve dialysis accessibility and affordability. The expansion of private dialysis center networks and the introduction of cost-effective technologies are also accelerating market penetration across the region.

Meanwhile, North America continues to dominate the global market, supported by a large ESRD patient population, advanced healthcare systems, and well-established reimbursement frameworks.

Competitive Landscape

Key players operating in the hemodialysis and peritoneal dialysis market include Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), and Nikkiso Co., Ltd. (Japan), among others.

These companies are focusing on technological innovation, expansion of dialysis center networks, and strategic collaborations to strengthen their global presence and address the growing demand for renal care services.

Related Reports:

Top 10 Medical Devices Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2031

Urology Devices Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hemodialysis-peritoneal-dialysis-market-to-reach-1415-billion-by-2031-driven-by-rising-esrd-burden-and-expansion-of-homebased-therapies]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.